v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net increase (decrease) in net assets resulting from operations $ (14,779,215) $ 2,134,189
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:    
Net realized (gains)/losses on investments 18,615,463 12,883,252
Net change in unrealized (gains)/losses on investments 30,877,332 25,378,309
Net accretion of discount on investments (1,627,988) (1,743,643)
Payment-in-kind interest and other income (2,270,684) (1,670,709)
Purchases of short-term investments (511,135,557) (447,866,247)
Purchases of portfolio investments (296,684,470) (335,350,462)
Proceeds from sale of short-term investments 522,706,111 462,833,964
Proceeds from sale of portfolio investments 355,577,236 433,678,517
Amortization of deferred financing cost 1,851,040 1,288,295
Increase/(decrease) in operating assets and liabilities:    
(Increase)/decrease in receivable for sales of investments (5,777,181) 183,807
(Increase)/decrease in interest and dividends receivable 1,420,519 2,837,984
(Increase)/decrease in due from investment adviser 0 (368,605)
(Increase)/decrease in receivable for paydowns of investments 115,803 234,215
(Increase)/decrease in prepaid expenses and other assets 37,771 (75,044)
Increase/(decrease) in interest payable on credit facilities (629,830) (1,393,892)
Increase/(decrease) in payable for investments purchased 9,358,619 (47,486,643)
Increase/(decrease) in management fees payable (321,273) (171,164)
Increase/(decrease) in incentive fee payable (204,791) (198,732)
Increase/(decrease) in accrued other general and administrative expenses 503,145 (213,682)
Net cash provided by (used in) operating activities 107,632,050 104,913,709
Cash Flows from Financing Activities:    
Borrowings on the credit facilities 12,000,000 45,100,000
Payments on the credit facilities (71,975,173) (96,800,000)
Payments of debt issuance costs (1,137,599) 0
Distributions paid in cash (36,950,923) (41,874,784)
Purchase of common shares for dividend reinvestment plan 0 514,649
Repurchase of common shares (10,905,044) (10,419,201)
Net cash provided by (used in) financing activities (108,968,739) (103,479,336)
Net increase/(decrease) in cash and cash equivalents (1,336,689) 1,434,373
Cash and cash equivalents, beginning of period 3,217,449 2,766,409
Cash and cash equivalents, end of period 1,880,760 4,200,782
Supplemental and Non-Cash Information:    
Interest paid during the period 32,196,483 39,697,517
Distributions declared during the period 35,002,467 39,629,393
Distributions payable $ 11,493,758 $ 13,404,534